16 08, 2024

Qkine is pleased to announce that it has been recertified with the international standard ISO 9001:2015 by globally respected UKAS-accredited BSI

2024-10-10T08:20:51+00:00August 16th, 2024|Awards, cellular agriculture, News, Press Release, quality|

Qkine is pleased to announce that it has successfully been recertified with the international standard ISO 9001:2015 by the globally respected UKAS accredited BSI, giving enhanced confidence in the assessment of best practices. This standard shows our dedication to raising the standard of bioactive proteins through implementation of continual improvement, scientific innovation and exceptional scientific and customer support

9 01, 2024

Nurturing Complexity: The role of vascularization in Organoid Advancements

2024-01-09T11:27:37+00:00January 9th, 2024|Blog, organoid news|

Organoids are exciting models that are rapidly becoming a hopeful platform for many medical advances such as drug screening and disease modeling. However, due to a lack of vascularization, they have limitations for future applications. This review blog summarizes several practical methods for successful organoid vascularization to date.

30 11, 2023

Hepatocyte-derived organoids provide unique insights into liver cell invasion by malaria parasites

2024-01-05T13:39:37+00:00November 30th, 2023|Blog, organoid news|

Complex 3D liver models that more closely mimic human biology open opportunities for improved drug and vaccine discovery for malaria and related parasitic diseases.

2 04, 2023

Cardiac organoids – the future of drug discovery?

2023-04-04T08:21:38+00:00April 2nd, 2023|Blog, organoid news|

Despite advances in research, around 90% of drugs fail during phase 1 clinical trials. New drugs for the treatment of cardiovascular disease and oncology have a particularly high failure rate, largely attributed to cardiotoxicity...

20 09, 2021

Revenge of the Organoids – Super Scientist saves the day

2021-09-20T20:15:43+00:00September 20th, 2021|#qkinetechtip, organoid news, protein engineering, Resources|

Can Super Scientist give you your organoid mojo back? Are your growth factors the reason your experiments fail? Can you use engineered or niche-specific growth factors to improve your organoid culture? Super Scientist flies in with easy fixes and questions to ask yourself - do you need to ditch the conditioned media, play around with growth factor combinations, switch noggin and gremlin, or be bold and explore new engineered proteins.

10 09, 2021

Qkine earns ISO 9001:2015 certification for protein R&D and manufacture facilities in Cambridge, UK

2024-08-15T06:47:24+00:00September 10th, 2021|Awards, cellular agriculture, News, Press Release, quality|

Qkine certified ISO9001: 2015 for its quality management system encompassing R&D, manufacturing, and operations in Cambridge, UK. Qkine supplies growth factors and cytokines to the fast-moving stem cell, organoid and emerging cultured meat sectors. Exceptional product quality and scientific support are crucial to customer's business processes and experimental outcomes.

25 11, 2020

Qkine, with UK biotechnology companies Manchester BIOGEL and Cellesce, is developing fully synthetic animal-free scaffolds to overcome barriers in sustainable and scalable organoid culture, in a project funded by Innovate UK

2022-02-07T13:30:35+00:00November 25th, 2020|animal-free, News, organoid news|

Qkine, Manchester BIOGEL and Cellesce have been awarded Innovate UK Sustainable Innovation Funding to develop fully synthetic, chemically-defined three-dimensional (3D) scaffolds to enable manufacture scale up and improve reproducibility of patient-derived organoids.

Go to Top